Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| 1 |
Microsoft
MSFT
|
+$572M |
| 2 |
Sherwin-Williams
SHW
|
+$570M |
| 3 |
Amazon
AMZN
|
+$440M |
| 4 |
NXP Semiconductors
NXPI
|
+$346M |
| 5 |
International Flavors & Fragrances
IFF
|
+$334M |
Top Sells
| 1 |
DuPont de Nemours
DD
|
+$222M |
| 2 |
CXO
CONCHO RESOURCES INC.
CXO
|
+$186M |
| 3 |
Booking.com
BKNG
|
+$122M |
| 4 |
EV
Eaton Vance Corp.
EV
|
+$104M |
| 5 |
iShares MSCI Taiwan ETF
EWT
|
+$80.1M |
Sector Composition
| 1 | Technology | 23.28% |
| 2 | Financials | 13.75% |
| 3 | Healthcare | 13.2% |
| 4 | Consumer Discretionary | 12.31% |
| 5 | Communication Services | 9.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3626
WPP
WPP
$5.89B
| $835K | ﹤0.01% |
13,078
+4,409
| +51% | +$282K |
|
|
PHAS
3627
DELISTED
PhaseBio Pharmaceuticals, Inc. Common Stock
PHAS
| $835K | ﹤0.01% |
241,513
+9,477
| +4% | +$32.8K |
|
3628
Flotek Industries
FTK
$336M
| $834K | ﹤0.01% |
82,781
+9,413
| +13% | +$94.8K |
|
3629
Landmark Bancorp
LARK
$156M
| $833K | ﹤0.01% |
38,336
+373
| +1% | +$8.11K |
|
|
FFNW
3630
DELISTED
First Financial Northwest, Inc
FFNW
| $833K | ﹤0.01% |
58,459
+540
| +0.9% | +$7.7K |
|
3631
Lantern Pharma
LTRN
$43.8M
| $831K | ﹤0.01% |
+45,830
| New | +$831K |
|
3632
LSB Industries
LXU
$591M
| $831K | ﹤0.01% |
210,616
| – | – |
|
3633
Sumitomo Mitsui Financial
SMFG
$107B
| $827K | ﹤0.01% |
114,097
+21,586
| +23% | +$156K |
|
|
APRN
3634
DELISTED
Blue Apron Holdings, Inc. Class A Common Stock
APRN
| $827K | ﹤0.01% |
10,931
+4,414
| +68% | +$334K |
|
3635
Natural Gas Services Group
NGS
$326M
| $827K | ﹤0.01% |
87,676
+2,781
| +3% | +$26.2K |
|
3636
AB InBev
BUD
$116B
| $826K | ﹤0.01% |
13,153
+676
| +5% | +$42.5K |
|
3637
Travelzoo
TZOO
$108M
| $825K | ﹤0.01% |
49,237
+5,061
| +11% | +$84.8K |
|
3638
PagSeguro Digital
PAGS
$2.78B
| $824K | ﹤0.01% |
17,811
+2,153
| +14% | +$99.6K |
|
3639
Usio Inc
USIO
$38.7M
| $824K | ﹤0.01% |
128,445
+64,921
| +102% | +$416K |
|
|
IDEX
3640
DELISTED
Ideanomics, Inc. Common Stock
IDEX
| $823K | ﹤0.01% |
2,256
+10
| +0.4% | +$3.65K |
|
3641
Aprea Therapeutics
APRE
$9.38M
| $821K | ﹤0.01% |
8,057
+672
| +9% | +$68.5K |
|
|
RNTX
3642
Rein Therapeutics, Inc. Common Stock
RNTX
$31.2M
| $817K | ﹤0.01% |
28,587
+17,121
| +149% | +$489K |
|
|
AGFS
3643
DELISTED
AgroFresh Solutions, Inc. Common Stock
AGFS
| $816K | ﹤0.01% |
408,407
-53,680
| -12% | -$107K |
|
3644
SELLAS Life Sciences
SLS
$196M
| $810K | ﹤0.01% |
94,907
+60,492
| +176% | +$516K |
|
3645
SEACOR Marine Holdings
SMHI
$176M
| $810K | ﹤0.01% |
152,066
| – | – |
|
|
TRIL
3646
DELISTED
Trillium Therapeutics Inc.
TRIL
| $810K | ﹤0.01% |
73,562
+2,105
| +3% | +$23.2K |
|
3647
US Global Investors
GROW
$32.3M
| $808K | ﹤0.01% |
115,780
+46,541
| +67% | +$325K |
|
|
ATXI
3648
DELISTED
Avenue Therapeutics, Inc. Common Stock
ATXI
| $804K | ﹤0.01% |
118
+7
| +6% | +$47.7K |
|
3649
Capricor Therapeutics
CAPR
$290M
| $802K | ﹤0.01% |
171,415
+49,569
| +41% | +$232K |
|
|
AIM
3650
AIM ImmunoTech Inc.
AIM
$7.02M
| $798K | ﹤0.01% |
3,518
+1,168
| +50% | +$265K |
|